Search research articles
Contact Us
Filters
Showing results (421-430 of 527) with videos related to
Page
of 53
Sort By:
Eclinicalmedicine
|
September 8, 2023
Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Anand V Kulkarni, Harshvardhan Tevethia, Karan Kumar, et al.
Journal of Global Oncology
|
May 25, 2019
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study
Seock-Ah Im, Hirofumi Mukai, In Hae Park, et al.
Investigational New Drugs
|
May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer
R S Finn, D H Ahn, M M Javle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
Dennis J Slamon, Véronique Diéras, Hope S Rugo, et al.
ESMO Open
|
August 21, 2020
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
Andrew X Zhu, Ryan D Nipp, Richard S Finn, et al.
Hepatology (Baltimore, Md.)
|
May 22, 2025
Galectin-1 modulates glycolysis through a GM1-galactose-dependent pathway to promote hyperthermia resistance in HCC
Tu Nguyen, Yonghwan Shin, Aravinth Ruppa, et al.
Liver Cancer
|
May 29, 2015
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma
Abby B Siegel, Anthony B El-Khoueiry, Richard S Finn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 18, 2018
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases
N C Turner, R S Finn, M Martin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
Feature consistency in transdiagnostic connectome-based models of sustained attention and autism symptoms
Corey Horien, Francesca Mandino, Anna Corriveau, et al.
Therapeutic Advances in Medical Oncology
|
October 7, 2021
ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240
Arndt Vogel, Philippe Merle, Chris Verslype, et al.
Page
of 53
Search research articles
Search
Showing results (421-430 of 527) with videos related to
Sort By:
Page
of 53
Eclinicalmedicine
|
September 8, 2023
Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Anand V Kulkarni, Harshvardhan Tevethia, Karan Kumar, et al.
Journal of Global Oncology
|
May 25, 2019
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study
Seock-Ah Im, Hirofumi Mukai, In Hae Park, et al.
Investigational New Drugs
|
May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer
R S Finn, D H Ahn, M M Javle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
Dennis J Slamon, Véronique Diéras, Hope S Rugo, et al.
ESMO Open
|
August 21, 2020
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
Andrew X Zhu, Ryan D Nipp, Richard S Finn, et al.
Hepatology (Baltimore, Md.)
|
May 22, 2025
Galectin-1 modulates glycolysis through a GM1-galactose-dependent pathway to promote hyperthermia resistance in HCC
Tu Nguyen, Yonghwan Shin, Aravinth Ruppa, et al.
Liver Cancer
|
May 29, 2015
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma
Abby B Siegel, Anthony B El-Khoueiry, Richard S Finn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 18, 2018
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases
N C Turner, R S Finn, M Martin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
Feature consistency in transdiagnostic connectome-based models of sustained attention and autism symptoms
Corey Horien, Francesca Mandino, Anna Corriveau, et al.
Therapeutic Advances in Medical Oncology
|
October 7, 2021
ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240
Arndt Vogel, Philippe Merle, Chris Verslype, et al.
Page
of 53